UoH granted patent for HIV drug combination efficacy enhancers

The University of Hyderabad (UoH) has been granted to patent “High active antiretroviral combination drugs loaded lactoferrin nanoparticles for first line and second line therapy” for targeted deliver

The University of Hyderabad (UoH) has been granted to patent “High active antiretroviral combination drugs loaded lactoferrin nanoparticles for first line and second line therapy” for targeted delivery of a combination of antiretroviral drugs to HIV-1 infected cells.

This has been developed in the laboratory for molecular therapeutics, Department of Biotechnology and Bioinformatics, School of Life Sciences, under the supervision of Anand K. Kondapi, a statement said.

The patented technology produces lactoferrin nanoparticles encapsulated in a combination of drugs in first line or second line therapy as a single drug product in an oral capsule for treatment of HIV-1.